↓ Skip to main content

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Overview of attention for article published in New England Journal of Medicine, March 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Readers on

mendeley
488 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 90 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 488 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 2 <1%
Netherlands 1 <1%
Spain 1 <1%
Unknown 484 99%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 58 12%
Other 49 10%
Student > Bachelor 47 10%
Student > Ph. D. Student 47 10%
Professor 27 6%
Other 114 23%
Unknown 146 30%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 189 39%
Pharmacology, Toxicology and Pharmaceutical Science 36 7%
Biochemistry, Genetics and Molecular Biology 32 7%
Nursing and Health Professions 14 3%
Agricultural and Biological Sciences 10 2%
Other 28 6%
Unknown 179 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 166. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2026.
All research outputs
#308,957
of 34,457,357 outputs
Outputs from New England Journal of Medicine
#5,239
of 38,407 outputs
Outputs of similar age
#5,349
of 369,043 outputs
Outputs of similar age from New England Journal of Medicine
#99
of 300 outputs
Altmetric has tracked 34,457,357 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,407 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 120.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,043 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 300 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.